Sasha S., Global Studies Asset Manager at Genentech, shared a post on LinkedIn:
“After 1.5 years at Summit Therapeutics, I’m closing this chapter.
The work was real. Oncology programs don’t move because of powerpoint slides- they move because of people who chase down the unglamorous problems before they become study-stopping ones. I worked alongside some of the best of them at Summit. Grateful for the colleagues who taught me, pushed me, and trusted me with hard problems.
You know who you are. Grateful for the patients we were racing for, even when they’ll never know our names. On to the next!”
Other articles on OncoDaily.